Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: Conventional and perfusion MRI revisited

Neuroradiology

Volumn 54, Issue 6, 2012, Pages 641-643

  Gupta, Ajay ^a   Omuro, Antonio M P ^b   Shah, Akash D ^a   Graber, Jerome J ^b   Shi, Weiji ^b   Zhang, Zhigang ^b   Young, Robert J ^b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

BRAIN PERFUSION; CANCER GRADING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION TENSOR IMAGING; DNA METHYLATION; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; IMAGE DISPLAY; LETTER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROMOTER REGION; TUMOR CLASSIFICATION;

BRAIN NEOPLASMS; DIAGNOSTIC IMAGING; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOMA; HUMANS; MALE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84862895140     PISSN: 00283940     EISSN: 14321920     Source Type: Journal    
DOI: 10.1007/s00234-011-0970-z     Document Type: Letter

References (5)

1. Moon WJ, Choi JW, Roh HG, Lim SD, Koh YC (2011) Imaging parameters of high grade gliomas in relation to the MGMT promoter methylation status: the CT, diffusion tensor imaging, and perfusion MR imaging. Neuroradiology. August 11. [in press]
2. Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 1;26(13):2192-2197
3. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 10;352(10):997-1003 (Pubitemid 40349502)
4. Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR (2010) An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging. Neuroimage. 15;49(2):1398-405. Epub 2009 Sep 28
5. Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G (2007) Methylation of O-6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival. Clin Cancer Res 1;13(9):2606-2613 (Pubitemid 46788026)